Missed opportunities for optimal antenatal corticosteroid timing in medically indicated preterm births

References

• Hamilton BE, Hoyert DL, Martin JA, et al. Annual summary of vital statistics: 2010–2011. Pediatrics. 2013;131(3):548–558.
   PubMed Web of Science ®Google Scholar
• Howson CP, Kinney MV, Lawn JE. Born too soon: the global action report on preterm birth. Geneva (Switzerland): World Health Organization; 2012.
   Google Scholar
• Carreno CA, Costantine MM, Holland MG, et al. Approximately one-third of medically indicated late preterm births are complicated by fetal growth restriction. Am J Obstet Gynecol. 2011;204(3):263.e1–263.e4.
   Web of Science ®Google Scholar
• Ananth CV, Vintzileos AM. Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth. Am J Obstet Gynecol. 2006;195(6):1557–1563.
   PubMed Web of Science ®Google Scholar
• Ananth CV, Joseph KS, Oyelese Y, et al. Trends in preterm birth and perinatal mortality among singletons: United States, 1989 through 2000. Obstet Gynecol. 2005;105(5):1084–1091.
   PubMed Web of Science ®Google Scholar
• Committee on Obstetric Practice. Committee opinion no. 713: antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol. 2017;130(2):e102–e109.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO recommendations on interventions to improve preterm birth outcomes. Geneva (Switzerland): WHO; 2015.
   Google Scholar
• Royal College of Obstetricians and Gynaecologists. Antenatal corticosteroids to reduce neonatal morbidity and mortality. London (UK): Royal College of Obstetricians and Gynaecologists; 2010. (Top Guideline No. 7).
   Google Scholar
• National Institutes of Health. Antenatal corticosteroids revisited: repeat courses. Stapleton (NY): NIH; 2000. (NIH Consensus Statement. 17–18).
   Google Scholar
• Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972;50(4):515–525.
   PubMed Web of Science ®Google Scholar
• Melamed N, Shah J, Soraisham A, et al. Association between antenatal corticosteroid administration-to-birth interval and outcomes of preterm neonates. Obstet Gynecol. 2015;125(6):1377–1384.
   PubMed Web of Science ®Google Scholar
• Norberg H, Kowalski J, Maršál K, et al. Timing of antenatal corticosteroid administration and survival in extremely preterm infants: a national population-based cohort study. BJOG. 2017;124(10):1567–1574.
   PubMed Web of Science ®Google Scholar
• Wilms FF, Vis JY, Pattinaja DA, et al. Relationship between the time interval from antenatal corticosteroid administration until preterm birth and the occurrence of respiratory morbidity. Am J Obstet Gynecol. 2011;205(1):49.e1–49.e7.
   Web of Science ®Google Scholar
• Norman M, Piedvache A, Børch K, et al. Association of short antenatal corticosteroid administration-to-birth intervals with survival and morbidity among very preterm infants: results from the EPICE cohort. JAMA Pediatr. 2017;171(7):678–686.
   PubMed Web of Science ®Google Scholar
• Sahasrabudhe N, Igel C, Echevarria GC, et al. Universal cervical length screening and antenatal corticosteroid timing. Obstet Gynecol. 2017;129(6):1104–1108.
   PubMed Web of Science ®Google Scholar
• Levin HI, Ananth CV, Benjamin-Boamah C, et al. Clinical indication and timing of antenatal corticosteroid administration at a single centre. BJOG. 2016;123(3):409–414.
   PubMed Web of Science ®Google Scholar
• Rottenstreich A, Levin G, Kleinstern G, et al. Patterns of use and optimal timing of antenatal corticosteroids in twin compared with singleton pregnancies. Acta Obstet Gynecol Scand. 2018;97(12):1508–1514.
   PubMed Web of Science ®Google Scholar
• Adams TM, Kinzler WL, Chavez MR, et al. The timing of administration of antenatal corticosteroids in women with indicated preterm birth. Am J Obstet Gynecol. 2015;212(5):645.e1–645.e4.
   Web of Science ®Google Scholar
• Crowther CA, McKinlay CJ, Middleton P, et al. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database Syst Rev. 2015;(7):CD003935.
   Google Scholar
• Makhija NK, Tronnes AA, Dunlap BS, et al. Antenatal corticosteroid timing: accuracy after the introduction of a rescue course protocol. Am J Obstet Gynecol. 2016;214(1):120.e1–120.e6.
   Web of Science ®Google Scholar
• Razaz N, Skoll A, Fahey J, et al. Trends in optimal, suboptimal, and questionably appropriate receipt of antenatal corticosteroid prophylaxis. Obstet Gynecol. 2015;125(2):288–296.
   PubMed Web of Science ®Google Scholar
• Sotiriadis A, Tsiami A, Papatheodorou S, et al. Neurodevelopmental outcome after a single course of antenatal steroids in children born preterm: a systematic review and meta-analysis. Obstet Gynecol. 2015;125(6):1385–1396.
   PubMed Web of Science ®Google Scholar
• Frändberg J, Sandblom J, Bruschettini M, et al. Antenatal corticosteroids: a retrospective cohort study on timing, indications and neonatal outcome. Acta Obstet Gynecol Scand. 2018;97(5):591–597.
   PubMed Web of Science ®Google Scholar
• Tuohy JF, Harding JE, Crowther CA, et al. Reported adherence to current antenatal corticosteroid guidelines in Australia and New Zealand. Aust N Z J Obstet Gynaecol. 2019;59(3):416–421.
   PubMed Web of Science ®Google Scholar
• Skoll A, Boutin A, Bujold E, et al. No. 364-Antenatal corticosteroid therapy for improving neonatal outcomes. J Obstet Gynaecol Can. 2018;40(9):1219–1239.
   PubMed Web of Science ®Google Scholar
• Khoo C, Welsh J, Owen P, et al. Antenatal corticosteroid prescribing: a complete audit cycle. J Obstet Gynaecol. 2007;27(1):33–36.
   PubMedGoogle Scholar